Master Transcriptional Regulators in Cancer: Discovery via Reverse Engineering Approaches and Subsequent Validation

Bruce Moran1,2, Arman Rahman1,2, Katja Palonen1,2

  • 1Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Research, UCD Conway Institute, University College Dublin, Dublin, Ireland.

Cancer Research
|April 22, 2017
PubMed

Insights

Master transcriptional regulators (MTRs) identified from gene expression data are key to understanding cancer. Validating these MTRs is crucial for clinical decisions and developing new cancer therapies.

Area of Science:

  • Oncology
  • Bioinformatics
  • Genomics

Background:

  • Transcriptional networks are crucial for understanding cancer development and progression.
  • Gene expression data analysis offers powerful methods for reverse engineering these networks.
  • Master transcriptional regulators (MTRs) are key genes within these networks, highly connected and implicated in disease.

Purpose of the Study:

  • To review methods for identifying Master Transcriptional Regulators (MTRs) from gene expression data.
  • To provide an overview of MTR validation strategies in oncology.
  • To highlight the clinical and therapeutic potential of validated MTRs in malignant diseases.

Main Methods:

  • Utilizing gene expression data to computationally identify MTRs within complex transcriptional networks.
  • Applying standardized bioinformatic approaches for network analysis and MTR discovery.
  • Reviewing established and emerging MTR validation techniques.

Main Results:

  • Complex transcriptional networks can be simplified to a core set of MTRs.
  • MTRs are highly connected genes central to biological processes in cancer.
  • Validation is essential to confirm the clinical relevance and therapeutic tractability of identified MTRs.

Conclusions:

  • MTR identification through gene expression analysis is a valuable tool in cancer research.
  • Robust validation of MTRs is critical for their translation into clinical practice.
  • Validated MTRs hold promise as biomarkers and therapeutic targets for cancer treatment.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.9K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.0K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.8K